In cardiac fibroblasts, angiotensin II (Ang II) can increase connexin 43 (Cx43) expression and promote calmodulin-dependent protein kinase II (CaMKII) activation. Cx43 overexpression is crucial for the fibroblast-myofibroblast transition. The main purpose of the present study was to investigate the role of CaMKII in regulating Cx43 expression and to determine whether the CaMKII/Cx43 pathway is essential for controlling fibroblast activation and differentiation. In vivo, 4 weeks of Ang II infusion enhanced CaMKII activation but reduced Cx43 expression in hearts undergoing fibrosis remodeling, while in cultured neonatal rat fibroblasts, CaMKII activation upregulated Cx43 expression via transforming growth factor-beta1 (TGF-β1). CaMKII inhibition by Ang-(1-7) or autocamtide 2-related inhibitory peptide reversed the Ang II-induced changes in Cx43 expression and attenuated Ang II-induced upregulation of alpha smooth muscle actin and TGF-β1 in both Ang II-infused rats and cultured fibroblasts. Based on the in vivo and in vitro experimental results, CaMKII plays a pivotal role in the Ang II-mediated fibroblast-myofibroblast transition by modulating the expressions of TGF-β1 and Cx43. We conclude that Ang II mediates the fibroblastmyofibroblast transition partially via the Ang II/CaMKII/TGF-β1/Cx43 signaling pathway.
Introduction
Calmodulin-dependent protein kinase II (CaMKII) is a well-described serine-threonine kinase that is closely related to cardiovascular diseases [1] . Excessive activation of CaMKII has been reported to be associated with heart failure, cardiac hypertrophy, and arrhythmia [2, 3] . Angiotensin (Ang II) can increase intracellular reactive oxygen species (ROS) and calcium levels, both of which promote CaMKII activation, but via different post-translational modifications. ROS enhances the oxidative activation of CaMKII by promoting the oxidation of methionine residues 281 and 282 (ox-CaMKII) [4] , while elevated calcium activates CaMKII via facilitating the autophosphorylation of threonine residues 286 and 287 (p-CaMKII) [4] . Recent studies suggested that CaMKII is involved in modulating cardiac fibroblast proliferation and fibroblast-myofibroblast transition (FMT). CaMKII inhibition significantly reduces the expressions of collagen I and III (Col I and Col III) induced by Ang II [5, 6] . CaMKII activation is necessary and sufficient for mediating fibroblast activation and differentiation.
There are three major connexin (Cx) isoforms in the normal heart, namely, Cx40, Cx43, and Cx45 [7] ; Cx43 and Cx45 are also expressed in fibroblasts [8] . In rat hearts, Cx43 knockdown significantly enhances fibroblast activity and cardiac fibrosis; thus, cardiac fibrosis leads to dispersed conduction and arrhythmia [9] . In cultured cardiac fibroblasts, previous studies have shown that Cx43 controls fibroblast phenotype conversion [10, 11] and maintains electrical and metabolic coupling between fibroblasts and cardiomyocytes [12] . Cx43 is closely linked with the physiological activities of fibroblasts.
A recent study suggested that an interaction exists between CaMKII and Cx43 in the heart. It has been demonstrated that CaMKII and its autophosphorylated form colocalize with Cx43 in intercalated disks [13] . CaMKII inhibition enhances Cx43 transfer to gap junctions in the hypertrophic heart [14] . In cardiomyocytes, CaMKII activation is closely related to Cx43 dysregulation. However, the interaction between CaMKII and Cx43 has been rarely reported in cardiac fibroblasts and warrants further investigation.
In this study, the effect of CaMKII on Cx43 expression was assessed in Ang II-infused rat models using osmotic micropumps and neonatal rat cardiac fibroblasts. Rats were given Ang-(1-7) or autocamtide 2-related inhibitory peptide (AIP), a specific CaMKII inhibitor. Results showed that CaMKII inhibition alleviated Ang II-induced upregulation of transforming growth factor-beta1 (TGF-β1) and alpha smooth muscle actin (α-SMA) and restored Cx43 expression in the myocardium. In cultured fibroblasts, Ang II increased Cx43 expression in a time-dependent manner through the CaMKII/TGF-β1 pathway. In addition, Cx43 appears as the initial agonist for α-SMA synthesis. Thus, our results suggested that the Ang II/CaMKII/TGF-β1/Cx43 signaling pathway plays an important role in mediating FMT.
Materials and Methods

Animal use and care
A total of 24 male Sprague-Dawley rats weighing 220 ± 20 g were used in this study, which were housed at 22 ± 2.0°C under a 12 h/ 12 h light/dark cycle and given food and water ad libitum. All procedures were approved by the Animal Care and Use Committee of Chongqing Medical University and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publications No. 8023, revised 1978). The rats were anesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg). Osmotic minipumps (model 2004; Alzet, Cupertino, USA) were subcutaneously inserted between the shoulder blades and hips. The 24 rats were randomly divided into four groups and subsequently treated with Ang II, at an infusion rate of 500 ng/ kg/min, Ang II plus Ang-(1-7) (500 ng/kg/min), or Ang II plus AIP (100 ng/kg/min) (Santa Cruz Biotech, Santa Cruz, USA), and control rats were infused with physiological saline solution for 28 days.
Histopathology and immunohistochemistry
The rats were euthanized with an overdose of pentobarbital. The hearts were immediately excised, briefly rinsed with phosphatebuffered saline (PBS), subsequently fixed in 4% paraformaldehyde and embedded in paraffin. The sections (5-μm thick) were then stained with picrosirius red staining reagent to evaluate the fibrotic areas. Immunohistochemical staining was performed to detect the expressions of α-SMA, TGF-β1, and Cx43 using anti-α-SMA antibody (Sigma, St Louis, USA), anti-TGF-β1 antibody (Proteintech, Rosemont, USA), and anti-Cx43 antibody (Abcam, Cambridge, USA), respectively. Cryosections (8-μm thick) of ventricular tissues were prepared as previously described [15] to detect the levels of ROS in the left ventricle. Briefly, the fluorescent dye dihydroethidium (DHE; Beyotime, Shanghai, China) was diluted in Hank's balanced salt solution at a concentration of 2 μM. The cryosections were incubated with DHE at 37°C for 30 min. To determine the expression of Cx43 in fibroblasts in tissues, the cryosections were incubated with polyclonal rabbit anti-Cx43 antibodies, followed by incubation with FITC-conjugated goat anti-rabbit IgG (green) (Cwbiotech, Beijing, China), and then with monoclonal anti-α-SMA antibody, followed by incubation with Cy3-conjugated goat anti-mouse IgG (red) (Cwbiotech), and finally detected with a Leica TCS SP8 confocal laser scanning microscope (Buffalo Grove, USA).
Western blot analysis
Protein extracts were separated by electrophoresis and transferred to polyvinylidene fluoride membranes (Roche Applied Science, Mannheim, Germany). Nonspecific protein was blocked with 5% nonfat milk, and then the membranes were incubated with primary antibodies against CaMKII, phosphorylated CaMKII (Thr-287, p-CaMKII), Col I, Col III (Abcam), oxidized-CaMKII (Met-281/282, ox-CaMKII) (GeneTex, San Antonio, USA), α-SMA, TGF-β1, and Cx43. The membranes were subsequently incubated with horseradish peroxidase-conjugated secondary antibodies. The immunoreactive bands were detected by a chemiluminescent substrate system (Invitrogen, Carlsbad, USA) and images were documented by ChemiDoc Imager (Bio-Rad, Hercules, USA). The intensities of each band were quantified using Image Lab 5.2.1 software (Bio-Rad). α-Tubulin expression was used as a loading control.
Rat cardiac fibroblast isolation and culture
Primary cardiac fibroblasts were isolated from neonatal SpragueDawley rat hearts (1 to 2 days old) as previously described [16] . The fibroblasts were resuspended in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (Gibco, Gaithersburg, USA), 100 U/ml penicillin, and 100 μg/ml streptomycin (Beyotime) and cultured in a humidified incubator containing 5% CO 2 . Only fibroblasts from passages one to two were used for the subsequent experiments and were treated as follows. To investigate the effect of Ang II on Cx43, fibroblasts were incubated with Ang II (10 μmol) for 24, 36, and 48 h. To knockdown TGF-β1, fibroblasts were transfected with small interfering RNA (siRNA) targeted against TGF-β1 (5′-GCAACAAUUCCUGGCGUUA-3′) or scrambled siRNA (5′-GC AUUAAGUCCGCGCAUUA-3′) as directed by the manufacturer (GenePharma, Shanghai, China). Furthermore, to evaluate the role of CaMKII in the regulation of Cx43 expression, fibroblasts were pretreated with AIP (1 μmol) or Ang-(1-7) (10 μmol) for 30 min before being exposed to Ang II for 36 h.
Immunocytochemistry assay
Neonatal rat fibroblasts were fixed and incubated with polyclonal rabbit anti-Cx43 antibodies, followed by incubation with DyLight 594-conjugated goat anti-rabbit IgG (red) (EarthOx, Millbrae, USA), and then with monoclonal anti-α-SMA antibody, followed by incubation with DyLight 488-conjugated goat anti-mouse IgG (green) (EarthOx). The nuclei were stained with 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI; KeyGEN, Beijing, China). Fluorescence intensities were quantified by Image-Pro Plus (version 6.0; Rockville, USA).
Dye transfer assay
Lucifer yellow dye can enter damaged cells and be transferred between the adjacent cells via functional gap junctions. The dye transfer distance reflects the functional status of gap junction intercellular communication (GJIC). After treatment, fully confluent fibroblasts were rinsed with PBS and scraped using a pipette tip and then incubated in PBS containing 0.5% Lucifer yellow CH, potassium salt (Invitrogen) for 5 min at 37°C [17] . Lucifer yellow dyecoupled fibroblasts were washed thrice with PBS, fixed with 4% paraformaldehyde, and photographed using a Nikon TE2000-U fluorescence microscope (Tokyo, Japan).
Statistical analyses
Data are expressed as the mean ± SEM for continuous variables. Differences between groups were evaluated by one-way ANOVA, and variables were compared between groups using Student's t-tests. All experiments were repeated at least three times. Statistical significance was defined at P < 0.05. All statistical analyses were performed using SPSS statistical software (version 19.0; SPSS Inc., Chicago, IL, USA).
Results
Ang-(1-7) and AIP administration decreased ventricular interstitial fibrosis and elevated oxidative stress in Ang II-infused hearts Ang II is a proinflammatory and profibrogenic cytokine [18] that is critical for mechanical and electrical cardiac remodeling. As shown in Fig. 1A , a high-dose and prolonged Ang II infusion led to decompensated cardiac hypertrophy. Thus, Ang II enhanced ventricular interstitial fibrosis with excessive collagen deposition (P < 0.01) and elevated ROS levels (P < 0.001) in hearts. We further evaluated the protective effects of Ang-(1-7) and AIP on Ang II-infused hearts. Ang-(1-7) has long been regarded as an effective endogenous inhibitor of the ACE/Ang II/AT1 axis, and AIP is often used as a CaMKII inhibitor [19, 20] . Activation of CaMKII is a key regulator of ROS production and cardiac remodeling [21] . Indeed, Ang-(1-7) and AIP administration alleviated cardiac hypertrophy, elevated oxidative stress and excessive collagen deposition in the Ang II-induced ventricular myocardium (P < 0.01; Fig. 1 ).
Ang-(1-7) and AIP administration decreased the expressions of TGF-β1 and α-SMA but restored the expression of Cx43 in Ang II-infused hearts
As shown in Fig. 2A,B , the results of immunohistochemistry and western blot analysis consistently demonstrated that Ang II markedly upregulated the expressions of α-SMA and TGF-β1 (P < 0.05) but downregulated the expression of Cx43 (P < 0.01) in the myocardium. Compared with those in Ang II-infused rat hearts, Ang-(1-7) and AIP treatments ameliorated the Ang II-mediated upregulation of TGF-β1 and α-SMA (P < 0.01) in rat hearts. However, the expression of Cx43 was significantly upregulated to basal levels in both Ang-(1-7)-and AIP-infused rats (P < 0.05). Furthermore, we precisely evaluated the expression of Cx43 in myofibroblasts in the heart. As expected, Ang II infusion reduced the expression of Cx43 in the intercalated disks of myocytes but induced the expression of α-SMA. However, Cx43-tagged tiny dots were almost invisible in α-SMA-positive areas. Nevertheless, both Ang-(1-7) and AIP could reverse the effects of Ang II treatment, restore Cx43 expression in intercalated disks, and promote heterocellular gap junctional coupling between myofibroblasts and cardiomyocytes.
Ang-(1-7) and AIP administration-inhibited CaMKII activation in Ang II-infused hearts
To determine whether Ang-(1-7) and AIP administration effectively inhibited CaMKII activation, we detected the expressions of phosphorylated CaMKII (Thr-287, p-CaMKII), oxidized-CaMKII (Met-281/282, ox-CaMKII), and total CaMKII. As shown in Fig. 3 , western blot analysis results indicated that Ang II (an agonist for CaMKII activation) significantly increased the expressions of p-CaMKII, ox-CaMKII, and total CaMKII (P < 0.05). Compared with Ang II infusion alone, Ang-(1-7) and AIP both inhibited the activity of CaMKII with reduced ratios of p-CaMKII/tubulin and CaMKII/tubulin (P < 0.01). In particular, AIP significantly reduced the p-CaMKII/CaMKII ratio (P < 0.05), whereas Ang-(1-7) downregulated ox-CaMKII expression more effectively (P < 0.05), suggesting that Ang-(1-7) and AIP might inhibit CaMKII activation through different ways in the heart under conditions of hyperactivity of the renin-angiotensin-aldosterone system (RAAS).
Increased expression of Cx43-promoted FMT in Ang II-induced cardiac fibroblasts
Although Ang II is crucial for the upregulation of Cx43 [22] , we wondered whether the expression patterns of Cx43 are related to FMT. As observed by Zhang et al. [17] , our neonatal rat cardiac fibroblast cultures also exhibited diffuse, punctate Cx43 immunoreactive signals. As shown in Fig. 4 , compared with the control treatment, Ang II significantly upregulated α-SMA expression at 36 h (P = 0.01) and 48 h (P = 0.001). Consistent with the changes in α-SMA, Ang II also increased the expression of Cx43 at 24 h (P = 0.001) and 36 h (P = 0.002), earlier than the time for the upregulation of α-SMA. However, once fibroblasts were highly differentiated into myofibroblasts at 48 h (P < 0.01), Ang II downregulated the expression of Cx43 to the baseline level (P = 0.66). Thus, Ang II-induced Cx43 expression first increased to a peak (24 and 36 h) and then gradually decreased to the resting level (48 h).
TGF-β1-mediated the expression of Cx43 in Ang II-induced neonatal rat cardiac fibroblasts
To clarify the role of TGF-β1 in Ang II-induced Cx43 expression, TGF-β1-targeting siRNA was used to knockdown endogenous TGF-β1 expression in fibroblasts. TGF-β is a locally generated cytokine which is important for fibroblast proliferation and the FMT [23] . As shown in Fig. 5 , TGF-β1-targeting siRNA effectively reduced TGF-β1 expression in Ang II-treated fibroblasts for 36 h (P < 0.01). Based on results of both immunocytochemistry and western blot analysis, TGF-β1-targeting siRNA significantly attenuated Ang II-induced α-SMA and Cx43 expressions in neonatal rat cardiac fibroblasts (P < 0.001).
CaMKII inhibition reduced Cx43 expression and attenuated Ang II-induced fibroblast differentiation
To evaluate whether CaMKII is involved in the regulation of Cx43 expression, we pretreated fibroblasts with Ang-(1-7) and AIP before treatment with Ang II for 36 h. Ang II significantly increased the expressions of Cx43 and α-SMA ( Fig. 6A , P < 0.05). Both Cx43 and α-SMA colocalized to the cytoplasm. Ang-(1-7) and AIP could partly reverse this effect. To further determine the effects of CaMKII on Cx43 expression and fibroblast differentiation, Western blot analysis was used to detect the protein levels of p-CaMKII, ox-CaMKII, and total CaMKII in Ang II-infused fibroblasts. As shown in Fig. 6B , results indicated that Ang II markedly promoted the activity of CaMKII by upregulating p-CaMKII and ox-CaMKII (P < 0.05). Compared with Ang II-only treatment, both Ang-(1-7) and AIP effectively weakened the activity of CaMKII by downregulating the expressions of p-CaMKII and ox-CaMKII (P < 0.05). Furthermore, upon CaMKII inhibition, Ang-(1-7) and AIP significantly reduced the expressions of α-SMA, TGF-β1, and Cx43 ( Fig. 6C , P < 0.05). The Western blot analysis results of α-SMA and Cx43 were consistent with the results of immunofluorescence, suggesting that CaMKII played a pivotal role in the regulation of Cx43 expression. Moreover, as shown in Fig. 6D , dye transfer assay revealed that higher expression of Cx43 was accompanied by a longer Lucifer yellow dye transfer distance, indicating that GJIC was promoted. As expected, CaMKII inhibition by Ang-(1-7) and AIP reduced GJIC (P < 0.05).
Discussion
In this study, we investigated the role of CaMKII in Ang II-mediated Cx43 expression and myofibroblastic differentiation in vivo and in isolated cardiac fibroblasts. The major findings of the present study are as follows: (i) Ang II enhanced the expression of Cx43 in a There are three major types of Cxs in the heart, namely, Cx40, Cx43, and Cx45, and cardiac fibroblasts mainly express Cx43 and Cx45 [24] . Recently, an increasing number of studies have focused on the function of Cx43 in fibroblasts and its interaction with cardiomyocytes [25] . In cultured fibroblasts, the upregulation of Cx43 participates in myofibroblastic differentiation [10, 11] , and Cx43 overexpression inhibits cardiac fibroblast proliferation [17] . As a potent agonist for fibroblast phenotype conversion, Ang II promotes the expression of Cx43 in cardiac fibroblasts [22] . Our data further showed that Ang II significantly increased the expression of Cx43 in a time-dependent manner. This phenomenon also exists in cardiomyocytes. Previous reports showed that cyclical mechanical stretching and rapid electrical stimulation, respectively, could increase Cx43 expression in a time-dependent manner in cultured neonatal rat cardiomyocytes [26, 27] . Double immunofluorescence of Cx43 and α-SMA also demonstrated that the time to upregulate Cx43 preceded that of α-SMA, indicating that Cx43 might act as the initial agonist of α-SMA synthesis. Two research groups reported that Cx43 competes with Smad 2/3 for binding to microtubules, which facilitates the translocation of Smad 2/3 and Smad 4 to the nucleus to activate the transcription of target genes [10, 28] . This translocation may be a potential mechanism explaining the relationship between Cx43 and α-SMA. Furthermore, we observed that once fibroblasts completely differentiated into myofibroblasts, Cx43 expression was drastically decreased. Baum et al. [29] revealed that IL-1β caused the loss of Cx43 in myofibroblasts and reduced the coupling between myofibroblasts and cardiomytes. Jansen et al. [9] found that Cx43 knockout significantly enhanced fibroblast activity and promoted excessive collagen deposition in remodeled hearts. The low expression of Cx43 seems to play an important role in maintaining the function of fibroblasts, but the potential mechanism needs to be further explored.
To further explore the mechanism of Ang II-mediated upregulation of Cx43 in cultured fibroblasts, we focused on the role of CaMKII. As a serine-threonine kinase, CaMKII is widely expressed in many tissues. The phosphorylation at Thr-287 and oxidation of Met-281/282 residues are the two major ways to activate CaMKII [30] . As reported in the previous studies, CaMKII and its autophosphorylated form colocalize with Cx43 at intercalated disks in the heart [13] . In addition, Cx43 has been proposed to be directly phosphorylated by CaMKII [31] . Cx43 and CaMKII have a close interaction. To the best of our knowledge, this study is the first to report the relationship between CaMKII and Cx43 in fibroblasts. Our data showed that Ang-(1-7) and AIP, a specific CaMKII inhibitor, attenuated the activity of CaMKII by decreasing the expressions of p-CaMKII and ox-CaMKII. Furthermore, CaMKII inhibitors effectively reduced the expressions of Cx43, TGF-β1, and α-SMA after 36 h of Ang II treatment, indicating that CaMKII plays a central role in mediating Ang II-induced Cx43 upregulation. Cx43 is the main component of gap junctional complexes. Gap junctions provide a low-resistance pathway for the transmembrane transport of low-molecular weight substances and electrical conduction [7, 32] . We, therefore, evaluated GJIC by dye transfer assay and found that the change in dye transfer distance was consistent with the expression of Cx43. CaMKII inhibition significantly reduced GJIC. This inhibition may impede signal transduction between fibroblasts themselves and between fibroblasts and cardiomyocytes. Consistent with the results of previous studies [6] , our data showed that CaMKII mediated the expression of TGF-β1; furthermore, recent studies have revealed that TGF-β1 increases Cx43 expression and GJIC activity [33] . Thus, we wondered if TGF-β1 is involved in Cx43-mediated fibroblast differentiation triggered by CaMKII activation. In cultured fibroblasts, TGF-β1-targeting siRNA significantly decreased Ang IIinduced Cx43 and α-SMA expressions, indicating that the TGF-β1-mediated upregulation of Cx43 might be a major contributor to the fibroblast differentiation induced by Ang II and CaMKII activation. The interaction between TGF-β1 and Cx43 is crucial for FMT [10, 11, 28] . Based on the results of in vitro experiments, we believe that the Ang II/CaMKII/TGF-β1/Cx43 signaling pathway plays an important role in fibroblast activation and phenotypic conversion.
We further evaluated the relationship between CaMKII and Cx43 in animal models. Adult Sprague-Dawley rats were infused with Ang II, at an infusion rate of 500 ng/kg/min, for 4 weeks with Alzet osmotic pumps. Consistent with the previous studies, the Ang II-infused hearts developed significant myocardial hypertrophy with increased ROS production and excessive collagen deposition [34, 35] . In addition, western blot results revealed that Ang II reduced the expression of Cx43 by enhancing the expressions of p-CaMKII, ox-CaMKII, TGF-β1, α-SMA, Col I, and Col III in the myocardium. However, these effects were partly ameliorated by AIP or Ang-(1-7), highlighting that CaMKII activation is closely associated with Cx43 dysregulation induced by Ang II. Although cardiomyocytes account for~30% of the cells in the heart, they occupy~80% of the normal myocardial tissue volume [36] . Therefore, the Western blot results in the heart mainly reflect the function of cardiomyocytes. Notably, the effects of CaMKII inhibition on Cx43 are different in different animal models. Zhong et al. [37] observed that CaMKII inhibition reduced Cx43 expression in high-fat diet-fed mice with hyperlipidemia. However, Takanari et al. [14] reported that mice with constitutively reduced CaMKII activity effectively restored Cx43 expression in a transverse constriction of the aorta model for 4 months. However, activation of RAAS usually results in diminished and heterogeneous Cx43 distribution in the remodeled heart [32, 38, 39] . Thus, a high-dose and prolonged Ang II infusion was found to lead to Cx43 downregulation in our study. In hypertrophic hearts, Kostin et al. [40] demonstrated that Cx43 upregulation occurred during the compensatory hypertrophy stage, whereas Cx43 expression was consistently decreased in various chronic heart diseases during the decompensated stage. This result may explain why CaMKII inhibition alleviates Ang II-induced Cx43 dysfunction, as it is widely accepted that hyperactive CaMKII promotes or deteriorates myocardial hypertrophy, arrhythmia, and heart failure [2, 3] . Furthermore, Waghabi et al. [41] demonstrated that TGF-β1 upregulation led to gap junctional reduction in Chagas cardiopathy. Consistent with the results of previous studies, our data showed that CaMKII inhibition reversed the Ang II-induced upregulation of TGF-β1, and normal level of TGF-β1 helped restore Cx43 expression in remodeled hearts. Therefore, we speculate that the Ang II/CaMKII/TGF-β1 signaling pathway plays an important role in modulating Cx43 expression.
To more accurately detect the expression of Cx43 in cardiac fibroblasts, we used double immunofluorescence to simultaneously label Cx43 and α-SMA. Indeed, Ang II infusion caused increased α-SMA-positive area, while Cx43 expression was almost invisible in these regions. However, Ang-(1-7) and AIP effectively reduced the number of α-SMA-positive cells and restored the gap junctions between cardiomyocytes, which is important to reduce arrhythmogenic matrix and maintain electrical conduction [14, 25, 29, 42] . Because fibroblasts in the heart are very small and the junctions between fibroblasts tend to be much smaller than those involving cardiomyocytes [17, 43] , it is very difficult to monitor changes in Cx43 in fibroblasts in vivo; the junctions in in vitro cultured fibroblasts tend to be larger.
In conclusion, our results confirmed that CaMKII is crucial for Ang II-mediated Cx43 expression, and the interaction between CaMKII and Cx43 determines FMT under conditions of hyperactivation of the RAAS. Thus, interference with the Ang II/CaMKII/ TGF-β1/Cx43 signaling pathway may delay the differentiation of cardiac fibroblasts into myofibroblasts and reduce collagen deposition and ultimately attenuate cardiac remodeling.
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